Publication: Quality of reporting randomized controlled trials (RCTs) in diabetes in Iran; a systematic review
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Gohari, Faeze, Hamid Reza Baradaran, Morteza Tabatabaee, Shabnam Anijidani, Fatemeh Mohammadpour Touserkani, Rasha Atlasi, and Maryam Razmgir. 2016. “Quality of reporting randomized controlled trials (RCTs) in diabetes in Iran; a systematic review.” Journal of Diabetes and Metabolic Disorders 15 (1): 36. doi:10.1186/s40200-016-0258-2. http://dx.doi.org/10.1186/s40200-016-0258-2.
Research Data
Abstract
Objective: To determine the quality of randomized controlled clinical trial (RCT) reports in diabetes research in Iran. Design: Systematized review. Methods: We included RCTs conducted on diabetes mellitus in Iran. Animal studies, educational interventions, and non-randomized trials were excluded. We excluded duplicated publications reporting the same groups of participants and intervention. Two independent reviewers identify all eligible articles specifically designed data extraction form. We searched through international databases; Scopus, ProQuest, EBSCO, Science Direct, Web of Science, Cochrane Library, PubMed; and national databases (In Persian language) such as Magiran, Scientific Information Database (SID) and IranMedex from January 1995 to January of 2013 Two investigators assessed the quality of reporting by CONSORT 2010 (Consolidated Standards of Reporting Trials) checklist statemen.t,. Discrepancies were resolved by third reviewer consulting. Results: One hundred and eight five (185) studies were included and appraised. Half of them (55.7 %) were published in Iranian journals. Most (89.7 %) were parallel RCTs, and being performed on type2 diabetic patients (77.8 %). Less than half of the CONSORT items (43.2 %) were reported in studies, totally. The reporting of randomization and blinding were poor. A few studies 15.1 % mentioned the method of random sequence generation and strategy of allocation concealment. And only 34.8 % of trials report how blinding was applied. Conclusions: The findings of this study show that the quality of RCTs conducted in Iran in diabetes research seems suboptimal and the reporting is also incomplete however an increasing trend of improvement can be seen over time. Therefore, it is suggested Iranian researchers pay much more attention to design and methodological quality in conducting and reporting of diabetes RCTs. Electronic supplementary material The online version of this article (doi:10.1186/s40200-016-0258-2) contains supplementary material, which is available to authorized users.
Description
Other Available Sources
Keywords
Diabetes, Randomized controlled trials, Iran, Systematized review
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service